tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Revenue

Compare
123 Followers

Virax Biolabs Group Ltd. Class A Revenue

Virax Biolabs Group Ltd. Class A had a revenue of 1.61K in the quarter ending Sep 30, 2025, with 16.69%. This bring the company's revenue in the last twelve months to 2.99K, Increased -52.84%. In the fiscal year ending Mar 31, 2025, Virax Biolabs Group Ltd. Class A had annual revenue of 6.33K with -95.95% growth.
Revenue (ttm)
2.99K
Revenue Growth
P/S Ratio
237.68
Revenue/Employee
$372
Employees
17
Market Cap
$1.50M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
6.33K-150.09K-95.95%
Mar 31, 2024
156.42K+∞%
Mar 31, 2023
Sep 30, 2022
-123.82K-100.00%
Mar 31, 2021
123.82K23.94K+23.97%
Mar 31, 2020
99.88K